Pyritinol: Difference between revisions
Jump to navigation
Jump to search
Created page with "<languages /> <translate> {{Short description|Chemical compound}} {{Infobox drug | Verifiedfields = changed | verifiedrevid = 464377508 | IUPAC_name = 5,5'-[dithiobis(methylene)]bis[4-(hydroxymethyl)-2-methylpyridin-3-ol] | image = Pyritinol.svg <!--Clinical data--> | tradename = | pregnancy_category = | legal_status = | routes_of_administration = <!--Pharmacokinetic data--> | bioavailability = | metabolism = | elimination_half-life = 2.5 hours | excretion =..." |
Marked this version for translation |
||
| Line 1: | Line 1: | ||
<languages /> | <languages /> | ||
<translate> | <translate> | ||
<!--T:1--> | |||
{{Short description|Chemical compound}} | {{Short description|Chemical compound}} | ||
{{Infobox drug | {{Infobox drug | ||
| Line 8: | Line 9: | ||
| image = Pyritinol.svg | | image = Pyritinol.svg | ||
<!--T:2--> | |||
<!--Clinical data--> | <!--Clinical data--> | ||
| tradename = | | tradename = | ||
| Line 14: | Line 16: | ||
| routes_of_administration = | | routes_of_administration = | ||
<!--T:3--> | |||
<!--Pharmacokinetic data--> | <!--Pharmacokinetic data--> | ||
| bioavailability = | | bioavailability = | ||
| Line 20: | Line 23: | ||
| excretion = | | excretion = | ||
<!--T:4--> | |||
<!--Identifiers--> | <!--Identifiers--> | ||
| CAS_number_Ref = {{cascite|changed|??}} | | CAS_number_Ref = {{cascite|changed|??}} | ||
| Line 36: | Line 40: | ||
| ChEMBL = 488093 | | ChEMBL = 488093 | ||
<!--T:5--> | |||
<!--Chemical data--> | <!--Chemical data--> | ||
| C=16 | H=20 | N=2 | O=4 | S=2 | | C=16 | H=20 | N=2 | O=4 | S=2 | ||
| Line 45: | Line 50: | ||
}} | }} | ||
<!--T:6--> | |||
'''Pyritinol''' also called pyridoxine disulfide or pyrithioxine (European drug names Encephabol, Encefabol, Cerbon 6) is a semi-synthetic water-soluble analog of [[vitamin B6|vitamin B<sub>6</sub>]] (Pyridoxine HCl). It was produced in 1961 by Merck Laboratories by bonding 2 vitamin B<sub>6</sub> compounds ([[pyridoxine]]) together with a disulfide bridge. Since the 1970s, it has been a prescription and OTC drug in several countries for cognitive disorders, rheumatoid arthritis, and learning disorders in children. Since the early 1990s it has been sold as a [[nootropic]] [[dietary supplement]] in the United States. | '''Pyritinol''' also called pyridoxine disulfide or pyrithioxine (European drug names Encephabol, Encefabol, Cerbon 6) is a semi-synthetic water-soluble analog of [[vitamin B6|vitamin B<sub>6</sub>]] (Pyridoxine HCl). It was produced in 1961 by Merck Laboratories by bonding 2 vitamin B<sub>6</sub> compounds ([[pyridoxine]]) together with a disulfide bridge. Since the 1970s, it has been a prescription and OTC drug in several countries for cognitive disorders, rheumatoid arthritis, and learning disorders in children. Since the early 1990s it has been sold as a [[nootropic]] [[dietary supplement]] in the United States. | ||
== Availability == | == Availability == <!--T:7--> | ||
It is approved for "symptomatic treatment of chronically impaired brain function in dementia syndromes" and for "supportive treatment of sequelae of craniocerebral trauma" in various European countries, including Austria, Germany, France, Italy, Portugal, and Greece. In France it is also approved for [[rheumatoid arthritis]] as a [[DMARD|disease modifying drug]], on the basis of the results of clinical trials. In many countries it is available over the counter and is widely advertised on the internet as being for "memory disturbances." | It is approved for "symptomatic treatment of chronically impaired brain function in dementia syndromes" and for "supportive treatment of sequelae of craniocerebral trauma" in various European countries, including Austria, Germany, France, Italy, Portugal, and Greece. In France it is also approved for [[rheumatoid arthritis]] as a [[DMARD|disease modifying drug]], on the basis of the results of clinical trials. In many countries it is available over the counter and is widely advertised on the internet as being for "memory disturbances." | ||
== Effects == | == Effects == <!--T:8--> | ||
''review refs needed'' | ''review refs needed'' | ||
== Adverse effects == | == Adverse effects == <!--T:9--> | ||
Adverse effects include nausea, headache, and rarely allergic reaction (mild skin reactions). A 2004 survey of six case reports suggested a link between pyritinol and severe [[cholestatic]] [[hepatitis]] when on several drugs for certain diseases. | Adverse effects include nausea, headache, and rarely allergic reaction (mild skin reactions). A 2004 survey of six case reports suggested a link between pyritinol and severe [[cholestatic]] [[hepatitis]] when on several drugs for certain diseases. | ||
<!--T:10--> | |||
Other rare side effects: acute pancreatitis and photoallergic eruption. | Other rare side effects: acute pancreatitis and photoallergic eruption. | ||
== See also == | == See also == <!--T:11--> | ||
* [[Emoxypine]] | * [[Emoxypine]] | ||
* [[Pirisudanol]] | * [[Pirisudanol]] | ||
* [[Sulbutiamine]] | * [[Sulbutiamine]] | ||
==External links== | ==External links== <!--T:12--> | ||
*{{Commons category-inline}} | *{{Commons category-inline}} | ||
<!--T:13--> | |||
{{Stimulants}}{{Vitamins}} | {{Stimulants}}{{Vitamins}} | ||
<!--T:14--> | |||
{{二次利用|date=23 March 2024}} | {{二次利用|date=23 March 2024}} | ||
[[Category:Antioxidants]] | [[Category:Antioxidants]] | ||
Latest revision as of 16:05, 4 April 2024
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Pharmacokinetic data | |
| Elimination half-life | 2.5 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C16H20N2O4S2 |
| Molar mass | 368.47 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Pyritinol also called pyridoxine disulfide or pyrithioxine (European drug names Encephabol, Encefabol, Cerbon 6) is a semi-synthetic water-soluble analog of vitamin B6 (Pyridoxine HCl). It was produced in 1961 by Merck Laboratories by bonding 2 vitamin B6 compounds (pyridoxine) together with a disulfide bridge. Since the 1970s, it has been a prescription and OTC drug in several countries for cognitive disorders, rheumatoid arthritis, and learning disorders in children. Since the early 1990s it has been sold as a nootropic dietary supplement in the United States.
Availability
It is approved for "symptomatic treatment of chronically impaired brain function in dementia syndromes" and for "supportive treatment of sequelae of craniocerebral trauma" in various European countries, including Austria, Germany, France, Italy, Portugal, and Greece. In France it is also approved for rheumatoid arthritis as a disease modifying drug, on the basis of the results of clinical trials. In many countries it is available over the counter and is widely advertised on the internet as being for "memory disturbances."
Effects
review refs needed
Adverse effects
Adverse effects include nausea, headache, and rarely allergic reaction (mild skin reactions). A 2004 survey of six case reports suggested a link between pyritinol and severe cholestatic hepatitis when on several drugs for certain diseases.
Other rare side effects: acute pancreatitis and photoallergic eruption.
See also
External links
Media related to Pyritinol at Wikimedia Commons
 | この記事は、クリエイティブ・コモンズ・表示・継承ライセンス3.0のもとで公表されたウィキペディアの項目Pyritinol(23 March 2024編集記事参照)を素材として二次利用しています。 Item:Q21787  |